Literature DB >> 1548939

Clinical importance of anthracyclines in the treatment of acute myeloid leukemia.

P H Wiernik1, J P Dutcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1548939

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.

Authors:  Linlin Zhong; Honglin Shen; Chenfei Huang; Hongwu Jing; Deliang Cao
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-26       Impact factor: 4.219

2.  Development of a tumor-specific photoactivatable doxorubicin prodrug.

Authors:  Albert W Girotti; Giorgio Minotti
Journal:  Photochem Photobiol       Date:  2013-09-03       Impact factor: 3.421

3.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

4.  The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines.

Authors:  D Kostrzewa-Nowak; M J I Paine; C R Wolf; J Tarasiuk
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

5.  Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid).

Authors:  Rameshwar Patil; Jose Portilla-Arias; Hui Ding; Bindu Konda; Arthur Rekechenetskiy; Satoshi Inoue; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Int J Mol Sci       Date:  2012-09-17       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.